首页 | 本学科首页   官方微博 | 高级检索  
     

逐瘀通脉胶囊联合长春西汀对慢性脑供血不足患者颈动脉斑块的影响
引用本文:刘国荣,王大力,张文丽,李旗,安亚臣,郑德松,李倩,张江. 逐瘀通脉胶囊联合长春西汀对慢性脑供血不足患者颈动脉斑块的影响[J]. 亚太传统医药, 2013, 0(8): 13-15
作者姓名:刘国荣  王大力  张文丽  李旗  安亚臣  郑德松  李倩  张江
作者单位:[1]河北联合大学,河北唐山063000 [2]河北联合大学附属医院神经内科,河北唐山063000 [3]河北联合大学医学实验研究中心,河北唐山063000
基金项目:唐山市科技局资助项目(10150222B-13)
摘    要:目的:探讨逐瘀通脉胶囊联合长春西汀注射液对慢性脑供血不足患者颈动脉粥样硬化斑块的影响及调脂作用。方法:将180例慢性脑供血不足患者随机分为四组,A组41例患者采用常规用药(抗血小板、营养神经,脑细胞活化剂)治疗;B组43例患者在A组用药基础上口服逐瘀通脉胶囊;C组45例患者在A组用药基础上静脉输入长春西汀注射液;D组51例患者在A组用药基础上采用逐瘀通脉胶囊联合长春西汀注射液治疗。观察比较各组临床疗效。结果:D组总有效率为96.07%,显著高于A组(60.97%)、B组(72.09%)和C组(73.33%),差异均有统计学意义(P〈0.05);D组治疗后颈动脉内膜中层厚度(TMT)、颈动脉粥样硬化斑块较治疗前明显改善(P〈0.05),且优于B组和C组(P〈0.05),且血管事件减少差异有统计学意义(P〈0.05)。结论:逐瘀通脉胶囊联合长春西汀注射治疗慢性脑供血不足,能更好地改善症状,调节血脂;可以稳定和减少颈动脉粥样硬化斑块形成,预防血管事件发生,疗效优于单纯使用逐瘀通脉胶囊或长春西汀。

关 键 词:逐瘀通脉胶囊  长春西汀注射液  慢性脑供血不足  颈动脉疾病  颈动脉斑块

Influence of Zhuyu Tongmai Capsule Combined with Vinpocetine of Carotid Plaques in Patients with Chronic Cerebral Circulation Insufficiency
Liu Guorong,Wang Dali,Zhang Wenli,Li Qi,An Yachen,Zheng Desong,Liqian,Zhang Jiang. Influence of Zhuyu Tongmai Capsule Combined with Vinpocetine of Carotid Plaques in Patients with Chronic Cerebral Circulation Insufficiency[J]. Asia-Pacific Traditional Medicine, 2013, 0(8): 13-15
Authors:Liu Guorong  Wang Dali  Zhang Wenli  Li Qi  An Yachen  Zheng Desong  Liqian  Zhang Jiang
Affiliation:1.Hebei United University,Hebei 063000,China;2.Department of Neurology, Affiliated Hospital Hebei United University,Hebei 063000,China; 3.Medical Experimental Center at Hebei United University,Hebei 063000,China)
Abstract:Objective:To investigate the joint capsules stasis tongmai vinpocetine injection on chronic cerebral insufficiency carotid atherosclerotic plaque effects and Lipid Metabolism.Methods:180 cases of chronic cerebral insufficiency were randomLy divided into four groups,A group of 41 patients were treated with conventional therapy(anti-platelet,nutrition,nerve,brain cell activator) treatment;B group,43 patients in Group A on the basis of oral medication stasis Tongmai Capsule;C group of 45 patients in Group A on the basis of intravenous drug vinpocetine injection;D group of 51 patients in group A drug based on the combined use of stasis Tongmai Capsule vinpocetine injection.Observe and compare the clinical efficacy of each group.Results:D group,the total effective rate was 96.07%,significantly higher than in group A(60.97%),B group(72.09%) and group C(73.33%),the differences were statistically significant(P0.05);D group therapy carotid intima-media thickness(TMT) cholesterol,carotid artery atherosclerotic plaque than before treatment significantly improved(P0.05),and better than group B and group C(P0.05),and the difference was reduced vascular events statistically significant(P0.05).Conclusion:Capsule combined with stasis tongmai vinpocetine injection therapy of chronic cerebral insufficiency,is able to improve the symptoms,regulate blood lipids,stabilize and reduce carotid atherosclerotic plaque formation,prevention of vascular events,more effective than simply use stasis tongmai capsules or vinpocetine.
Keywords:Zhuyu Tongmai Capsule  Vinpocetine Injection  Chronic Cerebral Circulation Insufficiency  Carotidartery Diseases  Carotid Artery Plaque
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号